Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06458556 · ClinicalTrials.gov registry record · NA
Transvaginal Radiofrequency Ablation for Overactive Bladder
A NA study, sponsored by InMode MD.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT06458556 is a NA study that has completed, run by InMode MD. The registered enrollment target is 17 participants.
The verdict
NCT06458556, a NA study, has completed, sponsored by InMode MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
To assess the effectiveness of transvaginal radiofrequency oblation by the Morpheus device at varying depths of penetration for improving urge predominate and urinary incontinence symptoms in women with overactive bladder .
Interventions
- DEVICE Treatment with Morpheus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2024-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06458556
The ClinicalTrials.gov registry entry for NCT06458556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InMode MD, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment with Morpheus is the first listed.
NCT06458556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06458556 about?
NCT06458556 is a clinical study titled "Transvaginal Radiofrequency Ablation for Overactive Bladder". To assess the effectiveness of transvaginal radiofrequency oblation by the Morpheus device at varying depths of penetration for improving urge predominate and urinary incontinence symptoms in women with overactive bladder .
What is the current status of trial NCT06458556?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2023-06-19. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT06458556?
The interventions under investigation include: Treatment with Morpheus (DEVICE).
Who is sponsoring clinical trial NCT06458556?
This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.